A study conducted with 30 T1D patients on hybrid closed loop (HCL) insulin pumps [18] evaluated glycemic control through telemedicine across four different time points during the pandemic lockdown period (two weeks before the lockdown, Time 0), during the first two weeks of lockdown (Time 1), last two weeks of lockdown (Time 2), and first two weeks after the lockdown (Time 3) [18]. Here, INS is linked to type 1 diabetes mellitus.